(Q36624112)

English

Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen

scientific article published on 17 October 2006

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

(E)-phytonadione

1 reference

based on heuristic

inferred from title

author name string

Elizabeth A Sconce

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Farhad Kamali

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

17 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

457-462

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Warfarin for non-valvar atrial fibrillation: still underused in the 21st century?

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Warfarin reversal

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Management of warfarin (coumarin) overdose

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Plasma disposition of vitamin K1 in relation to anticoagulant poisoning

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

The use of oral vitamin K for reversal of over-warfarinization

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Reversal of asymptomatic over-anticoagulation by orally administered vitamin K.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Treatment of warfarin-associated coagulopathy: a physician survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

A survey of oral vitamin K use by anticoagulation clinics

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Influence of body weight on response to subcutaneous vitamin K administration in over-anticoagulated patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.0902-4441.2006.T01-1-EJH2957.X

21 January 2018

Identifiers

10.1111/J.0902-4441.2006.T01-1-EJH2957.X

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36624112&oldid=1641628982"